544 related articles for article (PubMed ID: 17449306)
1. Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.
Klein T; Magerl W; Hanschmann A; Althaus M; Treede RD
Eur J Pain; 2008 Jan; 12(1):17-29. PubMed ID: 17449306
[TBL] [Abstract][Full Text] [Related]
2. CHF3381, a N-methyl-D-aspartate receptor antagonist and monoamine oxidase-A inhibitor, attenuates secondary hyperalgesia in a human pain model.
Mathiesen O; Imbimbo BP; Hilsted KL; Fabbri L; Dahl JB
J Pain; 2006 Aug; 7(8):565-74. PubMed ID: 16885013
[TBL] [Abstract][Full Text] [Related]
3. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.
Kraft B; Frickey NA; Kaufmann RM; Reif M; Frey R; Gustorff B; Kress HG
Anesthesiology; 2008 Jul; 109(1):101-10. PubMed ID: 18580179
[TBL] [Abstract][Full Text] [Related]
4. Effect of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects.
Wang H; Bolognese J; Calder N; Baxendale J; Kehler A; Cummings C; Connell J; Herman G
J Pain; 2008 Dec; 9(12):1088-95. PubMed ID: 19038771
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of peripheral ketamine and lidocaine on skin flux and hyperalgesia induced by intradermal capsaicin in humans.
Gottrup H; Bach FW; Jensen TS
Clin Physiol Funct Imaging; 2004 Mar; 24(2):103-8. PubMed ID: 15056183
[TBL] [Abstract][Full Text] [Related]
6. Analgesic effects of low-dose intravenous orphenadrine in the state of capsaicin hyperalgesia. A randomised, placebo-controlled, double-blind cross-over study using laser somatosensory evoked potentials obtained from capsaicin-irritated skin in healthy volunteers.
Schaffler K; Reitmeir P
Arzneimittelforschung; 2004; 54(10):673-9. PubMed ID: 15553107
[TBL] [Abstract][Full Text] [Related]
7. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.
Park KM; Max MB; Robinovitz E; Gracely RH; Bennett GJ
Pain; 1995 Nov; 63(2):163-172. PubMed ID: 8628581
[TBL] [Abstract][Full Text] [Related]
8. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
Wallace M; Schulteis G; Atkinson JH; Wolfson T; Lazzaretto D; Bentley H; Gouaux B; Abramson I
Anesthesiology; 2007 Nov; 107(5):785-96. PubMed ID: 18073554
[TBL] [Abstract][Full Text] [Related]
10. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
Juni A; Klein G; Kest B
Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of intravenous S-ketamine and fentanyl on atypical odontalgia and capsaicin-evoked pain.
Baad-Hansen L; Juhl GI; Jensen TS; Brandsborg B; Svensson P
Pain; 2007 May; 129(1-2):46-54. PubMed ID: 17088020
[TBL] [Abstract][Full Text] [Related]
12. Brain imaging of analgesic and antihyperalgesic effects of cyclooxygenase inhibition in an experimental human pain model: a functional MRI study.
Maihöfner C; Ringler R; Herrndobler F; Koppert W
Eur J Neurosci; 2007 Sep; 26(5):1344-56. PubMed ID: 17767511
[TBL] [Abstract][Full Text] [Related]
13. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
Rabben T; Skjelbred P; Oye I
J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
[TBL] [Abstract][Full Text] [Related]
14. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans.
Chizh BA; O'Donnell MB; Napolitano A; Wang J; Brooke AC; Aylott MC; Bullman JN; Gray EJ; Lai RY; Williams PM; Appleby JM
Pain; 2007 Nov; 132(1-2):132-41. PubMed ID: 17659837
[TBL] [Abstract][Full Text] [Related]
15. Late sensory function after intraoperative capsaicin wound instillation.
Aasvang EK; Hansen JB; Kehlet H
Acta Anaesthesiol Scand; 2010 Feb; 54(2):224-31. PubMed ID: 19681784
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the analgesic efficacy and psychoactive effects of AZD1940, a novel peripherally acting cannabinoid agonist, in human capsaicin-induced pain and hyperalgesia.
Kalliomäki J; Annas P; Huizar K; Clarke C; Zettergren A; Karlsten R; Segerdahl M
Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):212-8. PubMed ID: 23324098
[TBL] [Abstract][Full Text] [Related]
17. Human experimental pain models 3: heat/capsaicin sensitization and intradermal capsaicin models.
Modir JG; Wallace MS
Methods Mol Biol; 2010; 617():169-74. PubMed ID: 20336422
[TBL] [Abstract][Full Text] [Related]
18. N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain.
Pomonis JD; Harrison JE; Mark L; Bristol DR; Valenzano KJ; Walker K
J Pharmacol Exp Ther; 2003 Jul; 306(1):387-93. PubMed ID: 12721336
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of adrenosensitivity in capsaicin induced hyperalgesia.
Schattschneider J; Zum Buttel I; Binder A; Wasner G; Hedderich J; Baron R
Eur J Pain; 2007 Oct; 11(7):756-63. PubMed ID: 17234439
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
Ranoux D; Attal N; Morain F; Bouhassira D
Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
